Small Molecule Inhibitors of Human Adipocyte Fatty Acid Binding Protein (FABP4) | |
Zhang, Mingming1; Zhu, Weiliang2; Li, Yingxia1 | |
刊名 | MEDICINAL CHEMISTRY |
2014-06 | |
卷号 | 10期号:4页码:339-347 |
关键词 | Fatty acid binding protein 4 FABP4 inhibitor receptor small molecule type 2 diabetes |
ISSN号 | 1573-4064 |
DOI | 10.2174/15734064113096660045 |
文献子类 | Article |
英文摘要 | Fatty acid binding protein 4 (FABP4) is expressed in adipocytes and macrophages, and modulates inflammatory and metabolic response. Studies in FABP4-deficient mice have shown that this lipid carrier has a significant role within the field of metabolic syndrome, inflammation and atherosclerosis; thus, its inhibition may open up new opportunities to develop novel therapeutic agents. A number of potent small molecule inhibitors of FABP4 have been identified and found to have the potential to prevent and treat metabolic diseases such as type-2 diabetes and atherosclerosis. Due to the ubiquity of endogenous fatty acids and the high intracellular concentration of FABP4, the inhibitors need to have significantly greater intrinsic potency than endogenous fatty acids. Furthermore, heart-type FABP (FABP3), which is expressed in both heart and skeletal muscle, is involved in active fatty acid metabolism where it transports fatty acids from the cell membrane to mitochondria for oxidation. However, FABP3 shares high overall sequence identity and similar 3D structure with FABP4, but has a potential problem with selectivity. In this review, we would like to analyze the main inhibitors that have appeared in the literature in the last decade, focusing on chemical structures, biological properties, selectivity and structure-activity relationships. |
资助项目 | National High-tech R&D Program of China[2011AA09070105] |
WOS关键词 | HORMONE-SENSITIVE LIPASE ; ACTIVATED RECEPTOR-GAMMA ; INSULIN-RESISTANCE ; AP2 ; OBESITY ; MICE ; ATHEROSCLEROSIS ; DESIGN ; AFABP ; CELL |
WOS研究方向 | Pharmacology & Pharmacy |
语种 | 英语 |
出版者 | BENTHAM SCIENCE PUBL LTD |
WOS记录号 | WOS:000334852400001 |
内容类型 | 期刊论文 |
源URL | [http://119.78.100.183/handle/2S10ELR8/277062] |
专题 | 药物发现与设计中心 |
通讯作者 | Li, Yingxia |
作者单位 | 1.Fudan Univ, Sch Pharm, Shanghai 201203, Peoples R China; 2.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China |
推荐引用方式 GB/T 7714 | Zhang, Mingming,Zhu, Weiliang,Li, Yingxia. Small Molecule Inhibitors of Human Adipocyte Fatty Acid Binding Protein (FABP4)[J]. MEDICINAL CHEMISTRY,2014,10(4):339-347. |
APA | Zhang, Mingming,Zhu, Weiliang,&Li, Yingxia.(2014).Small Molecule Inhibitors of Human Adipocyte Fatty Acid Binding Protein (FABP4).MEDICINAL CHEMISTRY,10(4),339-347. |
MLA | Zhang, Mingming,et al."Small Molecule Inhibitors of Human Adipocyte Fatty Acid Binding Protein (FABP4)".MEDICINAL CHEMISTRY 10.4(2014):339-347. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论